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NOSBeing the largest form of intravascular and tissue storage of nitric oxide (NO) and a signalling molecule itself,
the nitrite anion (NO2−) has emerged as a key player in many biological processes. Since the heart is under an
important NO-mediated autocrine–paracrine control, in mammals the cardiac effects of nitrite are under
intensive investigation. In contrast, nothing is known in non-mammalian vertebrates. We evaluated nitrite
inﬂuence on cardiac performance in the perfused beating heart of three different cold-blooded vertebrates,
i.e. two teleost ﬁshes, the temperate red-blooded Anguilla anguilla, the Antarctic stenotherm, hemoglobinless
Chionodraco hamatus (iceﬁsh), and the frog Rana esculenta. We showed that, under basal conditions, in all
animals nitrite inﬂuences cardiac mechanical performance, inducing negative inotropism in eel and frog,
while being a positive inotrope in C. hamatus. In all species, these responses parallel the inotropic effects of
authentic NO. We also demonstrated that the nitrite-dependent inotropic effects are i) dependent from NO
synthase (NOS) activity in ﬁsh; ii) sensitive to NO scavenging in frog; iii) cGMP/PKG-dependent in both eel
and frog. Results suggest that nitrite is an integral physiological source of NO and acts as a signalling molecule
in lower vertebrate hearts, exerting relevant inotropic actions through different species-speciﬁc mechanisms.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Over recent years, the biology of inorganic nitrogen oxides has
been the subject of many investigations. Although knowledge on their
biological effects of nitrite has a long and rich history, the emerging
role of nitrite as a nitric oxide (NO) reservoir in mammals, including
man, opened the door to novel implications both at physiological and
pathological levels [1,2].
Nitrite anion (NO2−) is relatively abundant in blood and tissues
and its plasma levels are conserved across various mammalian
species, including man, in the range of 150–600 nmol l−1 and may
increase slightly in response to inﬂammation or infection [3,4]. It was
estimated that as much as 70% of plasma nitrite originates from nitric
oxide synthases (NOSs), mainly in the endothelium by endothelial
NOS (eNOS). In fact, nitrite has been reported as an index of NOSs
activity [1]. In addition to endogenous generation, exogenous sources,
principally environmental pollutants and intake of vegetables, con-
tribute to the build-up of this NO reserve [5].
A growing body of evidence suggests that nitrite anion, rather than
being an inert waste product of NOmetabolism, may be a key player inll rights reserved.biological processes, representing, on one hand, the largest form of
intravascular and tissue storage pool of NO and, on the other hand, a
signalling molecule itself [6].
Mechanisms for the in vivo conversion of nitrite to NOmay involve
either enzymatic reduction or non-enzymatic reduction [see2 for
references]. Some proteins show nitrite reductase capacity, i.e.
glutathione-S-transferases, xanthine oxidoreductase, cytochrome P-
450 enzymes, deoxy-hemoglobin and deoxy-myoglobin, as well as
eNOS [7,8]. Each mechanism would occur preferentially during
pathological hypoxia and acidosis[9] present in disease states, such
as ischemia [10]. In fact, during ischemia this alternative NO
production may exert a protective inﬂuence because L-arginine-
NOS-derived NO generation depends on oxygen, which is rapidly
depleted under ischemic conditions. Accordingly, recent evidence is
consistent with a powerful protective inﬂuence of nitrite in animal
models of ischemia–reperfusion injury [10,11]. It was suggested that
nitrite acts via formation of NO, but there is also a possibility that
nitrite can modulate physiological processes via other pathways, for
example through direct S-nitrosylation of thiol-containing proteins.
Recently, some authors have reported that nitrite has a distinct and
important signalling role under normal physiological conditions,
being capable of modulating many important signalling pathways,
including soluble guanylyl cyclase (sGC) stimulation, cytochrome P-
450 activity and the expression of two archetypical proteins, heat
shock protein 70 (Hsp 70) and heme oxygenase-1 (HO-1) [12]. Nitrite
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blooded vertebrates, particularly ﬁsh and amphibians, and therefore
we may expect that in these animal groups the anion-elicited effects
may be, at least, as important as in mammals. Furthermore, many ﬁsh
and amphibians are chronically exposed to the challenge of environ-
mental hypoxia and acidosis. For the ﬁrst time in ﬁsh, Jensen [13]
tested the hypothesis that NO2− accumulation across the gills of
zebraﬁsh causes a relevant production of NO from nitrite. He used de-
convolution spectral methodology and blood level of nitrosylhemo-
globin (HbNO), as a biomarker of intra-organismal NO generation, and
showed very high HbNO levels in ﬁsh exposed for variable time
periods to different doses of nitrite (dissolved as NaNO2 in the
environmental water). This ﬁnding is consistent with deoxyHb-
mediated reduction of nitrite as a major NO-producing mechanism
which appears physiologically important in the in vivo arterial-venous
circulation when Hb circulates between full and intermediate oxygen
saturation. The aim of this research was to explore the biological
activity of nitrite as a putative signalling molecule under basal
conditions in isolated and perfused working hearts (teleost ﬁshes and
frog), selected as appropriate case study models of lower vertebrate
cardiac physiologies.
We used the temperate eurytherm European eel (Anguilla anguilla)
and the cold-adapted Antarctic Chionodraco hamatus (iceﬁsh) and the
frog Rana esculenta. Both eel and frog experience considerable
ﬂuctuations of environmental oxygen, the former being a champion
of prolonged hypoxia and acidosis tolerance. In contrast, the iceﬁsh
represents a unique case of extreme stenothermia; in fact, it is an
endemic inhabitant of the stably icy and richly oxygenated Antarctic
waters. Conceivably, these environmental conditions have allowed the
animal to survive despite its paradoxical loss of hemoglobin and red
blood cells, normally indispensable for adult vertebrate life [see 14,15
for references]. Since Hb is a key protein in NO homeostasis,
functioning both as NO scavenger and generator from nitrite, the
hemoglobinless iceﬁsh provides exclusive opportunities to investigate
NO/nitrite signalling in a naturally occurring genetic knockout for Hb.
This comparative analysis may be of relevance to understand the
biological activity of nitrite inmodulating the “normal” function of the
vertebrate heart, verifying, at the same time, to which extent aspects
of cardiovascular regulation and even classiﬁcation of NO and nitrite-
dependent mechanisms can be applied to representatives of more
than one group (mammals) of vertebrates.
2. Materials and methods
2.1. Chemicals
Biotin-HPDP was purchased from Pierce; ECL was purchased from
Amersham; the other chemicals/drugs were purchased from Sigma
unless otherwise indicated and prepared immediately before each
experiment. ODQ was prepared in ethanol, while the other solutions
were prepared in double-distilled water. KT5823 was used in a
darkened perfusion apparatus to prevent degradation.
2.2. Animals
European eels (A. anguilla L.) and frogs (R. esculenta) of both sexes,
weighing 90–120 g and 15–25 g respectively, were provided by a local
hatchery and kept at room temperature (18–20 °C) without feeding
for 5–7 days.
Male and female iceﬁsh (C. hamatus), weighing 320–370 g, were
caught by nets in the Terranova Bay, Ross Sea, Antarctica during
January 2005. The animals were maintained unfed for at least 5 days
in aerated, running seawater at temperatures between 0 and 2 °C. The
experiments were done in the Italian Antarctic Base laboratories,
Terranova Bay (74°42′S,164°06′E), during the XX Italian Antarctic
Expedition (December 2004–February 2005).All animals were treated in accordance with the Guide for the Care
and Use of Laboratory Animals published by the US National Institutes
of Health.
2.3. Isolated and perfused working heart preparations
Both ﬁsh (eel and iceﬁsh) were anaesthetized in benzocaine
(0.2 g l−1) for 15 min and were opened ventrally. The ventral aorta
was cannulated and the heart removed without the pericardium and
placed in an ice-chilled dish ﬁlled with saline for the atrium
cannulation procedure. A polyethylene cannula was secured in the
atrium at the junction with the sinus venosus. Isolation time was
5 min.
Frogs were pited and ventrally opened; the pericardium was
removed and the heart cannulated in situ with polyethylene cannula
inserted into the sinus venosus for the inﬂow and into the left aortic
trunk for outﬂow collection. Right aortic trunk, right and left praecava
veins and pulmonary vein were tied off by ligature. Isolation time was
15–20 min.
The cannulated heart was transferred to a perfusion chamber ﬁlled
with saline and connected with a perfusion apparatus as previously
described [eel, 16; iceﬁsh, 17; frog, 18]. Perfusion was immediately
started; the heart received saline from an input reservoir pumped
against an afterload pressure given by the height of an output
reservoir.
The hearts were perfused with Ringer's solution at constant input
pressures and were able to produce physiological values of work and
power [eel, 16; iceﬁsh, 17; frog, 18]. The experiments on eel and frog
were performed at room temperature (18–20 °C), the experiments on
iceﬁsh were performed in a cold thermostatted cabinet (LKB 2021
Maxicoldlab, Malbo, Sweden), which allowed the heart and perfusion
system to be maintained at near zero temperatures. The control
conditions were: A. anguilla, mean output pressure 3.00 kPa with
cardiac output set to 10 ml min−1 kg−1 body mass; C. hamatus, mean
output pressure 1.4 kPa with cardiac output set to 50 ml min−1 kg−1
body mass; R. esculenta, mean output pressure 3.92 kPa with cardiac
output set to 110mlmin−1 kg−1 bodymass. Cardiac output was set by
appropriately adjusting ﬁlling pressure.
Heart rate (HR) was calculated from pressure recording curves.
Cardiac output (CO) was collected over 1 min and weighed; values
were corrected for ﬂuid density and expressed as volume measure-
ments. Stroke volume (Vs; ml kg−1; CO/HR) was used as a measure of
ventricular performance; changes in Vs were considered to be
inotropic effects. CO and Vs were normalized per kilogram of wet
body mass. Ventricular stroke work [Ws; mJ g−1; (afterload–
preload)×Vs/ventricle mass] served as an index of systolic function-
ality. Ws was corrected for the ventricle weights (eel, 0.065±0.003;
iceﬁsh, 1.12±0.23; frog, 0.048±0.002) measured at the end of each
experiment after the removal of excess water.
2.4. Experimental protocol
In all experiments, hearts were allowed to equilibrate to conditions
which simulate an in vivo resting state for up to 15–20 min. Hearts
that did not stabilize within 20 min of perfusion were discarded.
Cardiac variables were measured simultaneously during experiments.
All experiments were carried out on the basis of endurance proﬁle for
each species (eel, 120 min, [16]; iceﬁsh, 120 min, [17]; frog, 80 min,
[18]). To avoid the inﬂuence of chronotropism on inotropism, all the
hearts were electrically paced at spontaneous rhythm. However,
control experiments on unpaced heart (data not shown) revealed that
nitrite did not modify HR.
The response of the hearts to pharmacological agents (L-arginine:
eel 10−7 mol l−1, iceﬁsh 10−6 mol l−1 [17], frog 10−7 mol l−1;
L-NMMA: 10−5 mol l−1; SIN-1: eel 10−7 mol l−1, iceﬁsh 10−5 mol l−1
[17], frog 10−7 mol l−1; SOD: 10 IU/ml; L-NIO: 10−5 mol l−1; PTIO:
Table 1
Baseline cardiac parameters in working hearts.
Species Heart rate (beats/min) Filling pressure (kPa) Output pressure (kPa) Cardiac output (ml min−1 kg−1) Stroke volume (ml min−1 kg−1) Stroke work (mJ g−1)
Eel 51.4±12.2 0.07±0.008 2.97±0.034 10.9±1.56 0.21±0.09 0.105±0.03
Iceﬁsh 31.2±0.79 0.117±0.011 1.385±0.085 50.5±3.62 1.861±0.113 2.241±0.258
Frog 55.4±2.8 0.5±0.05 3.76±0.1 107.4±3.62 1.96±0.39 4.15±0.32
Fig. 1. Cumulative dose–response curves of nitrite on stroke volume (Vs) and stroke
work (Ws) in isolated and perfused hearts of eel, iceﬁsh and frog (n=5). Percentage
changes were evaluated as means±S.E.M. Asterisks indicate values signiﬁcantly
different from the control value: ⁎Pb0.05.
851M.C. Cerra et al. / Biochimica et Biophysica Acta 1787 (2009) 849–85510−7 mol l−1; ODQ: 10−5 mol l−1; KT5823: 10−7 mol l−1) was
obtained by perfusing each cardiac preparations with the buffer
containing only one chemical at the desired concentration in the
presence or absence of increasing concentrations of sodium nitrite.
2.5. Statistics
Data were expressed as the mean±SEM. Since each heart
represents its own control, the statistical signiﬁcance of differences
within-group was assessed using the paired Student's t-test (Pb0.05).
Comparison between groups was made using a one-way analysis of
variance (ANOVA) followed by Duncan's test. Differences were
considered to be statistically signiﬁcant for Pb0.05.
2.6. Homogenization protocol
Hearts were homogenized on ice in 20 mmol l−1 Tris pH 7.5,
150 mmol l−1 NaCl, 1% Igepal CA 630, 0.5% Sodium Deoxycholate,
1 mmol l−1 EDTA, 0.1% SDS, 200 mmol l−1 Sodium Orthovanadate,
and Protease Inhibitor Cocktail, using a polytron tissue grinder. The
homogenate was centrifuged at 4 °C for 40 min at 13,000 g. The
supernatant containing cytosolic proteins was collected and proteins
were quantiﬁed with Bradford reagent; the pellet containing
membrane proteins was resuspended in homogenization buffer and
proteins were quantiﬁed with Bradford reagent.
2.7. Biotin switch assay and Western blot
The biotin switch assay was performed essentially as previously
described [19]. Extracts were adjusted to 0.5 mg/ml of protein and
equal amounts were blocked with 4 volumes of blocking buffer
(225 mmol l−1 Hepes, pH 7.7, 0.9 mmol l−1 EDTA, 0.09 mmol l−1
neocuproine, 2.5% SDS, and 20 mmol l−1 MMTS) at 50 °C for 20 min
with agitation. After blocking, extracts were precipitated with 2
volumes of cold (−20 °C) acetone, chilled at −20 °C for 10 min,
centrifuged at 2000 g, 4 °C for 5 min, washed with acetone, dried out
at room temperature and resuspended in 0.1 ml HENS buffer
(250 mmol l−1 Hepes, pH 7.7, 1 mmol l−1 EDTA, 0.1 mmol l−1
neocuproine, and 1% SDS) x mg of protein. Until this step, all
operations were carried out in the dark. A 1/3 vol of biotin-HPDP
4 mmol l−1 in DMF and ascorbate 1 mmol l−1 were added and
incubated for 1 h at room temperature. Proteins were acetone-
precipitated again and resuspended in the same volume of HENS
buffer.
To detect biotinylated proteins by Western blot, samples from the
biotin switch assay were separated on 15% SDS-PAGE gels, transferred
to PVDF membranes, blocked with non fat dried milk, and incubated
with streptavidin-peroxidase diluted 1/5000 for 1 h.
Blots were developed by enhanced chemioluminescence (ECL) and
were placed in a ﬁlm cassette with photograph ﬁlm. Films were
exposed for 30 s, developed and ﬁxed.
3. Results
3.1. Isolated and perfused working heart preparations
Under basal conditions, the hemodynamic characteristics of the
isolated and perfused working heart preparations from eel, iceﬁsh,and frog mimic the physiological values of the in vivo animal. Baseline
hemodynamic parameters of all species (heart rate, ﬁlling pressure,
output pressure, cardiac output, stroke volume, and stroke work)
were measured after 15–20 min of equilibration (Table 1). The iceﬁsh
cardiac output shown in Table 1 is an in vitro value obtained by us
using the preparation of isolated and perfused working heart. This
value is very close to the cardiac output calculated in vivo (61 ml
min−1 kg−1 [20]).
3.2. Nitrite modulation of inotropism
To assess the effects of nitrite on cardiac function, the isolated
perfused cardiac preparations from eel, iceﬁsh, and frog were exposed
to nitrite and parameters of cardiac function were measured. In
control experiments repeated exposures of each heart to the same
concentration of nitrite did not result in pharmacological tolerance
(data not shown), therefore cumulative concentration-response
curves were generated.
In both eel and frog, nitrite induced a concentration-dependent
negative inotropic effect, shown by a decrease in stroke volume and
Fig. 3. Effect of nitrite (10−5 mol l−1) on stroke volume (Vs) and stroke work (Ws) in
isolated and perfused hearts of eel, iceﬁsh and frog before (A) and after treatment with
L-NMMA (10−5 mol l−1) (B) or L-NIO (10−5 mol l−1) (C) or PTIO (10−7 mol l−1) (D)
(n=4–6). Percentage changes were evaluated as means±S.E.M. Asterisks indicate
values signiﬁcantly different from the control value: ⁎Pb0.05.
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10−5 mol l−1 in the frog. In contrast, in the hemoglobineless iceﬁsh,
increasing concentrations of nitrite positively modulated inotropism,
as indicated by an increase in stroke volume and stroke work,
signiﬁcant from 10−7 mol l−1 (Fig. 1).
3.3. Inotropic effects induced by authentic nitric oxide
To determine the effects of endogenously generated NO on cardiac
function, we treated the isolated heart preparations with the
physiological substrate for NO synthase (NOS), L-arginine and a pure
NOS-independent NO donor, SIN-1. We tested several doses of
L-arginine and SIN-1 and we have chosen the lowest concentration
which is able to induce signiﬁcant effects.
As shown in Fig. 2A, similar to the effects observed with nitrite,
stroke volume and stroke work were signiﬁcantly decreased by
L-arginine in eel and frog, while they were increased in the iceﬁsh. In
all species, the L-arginine-dependent effects were inhibited by the
NOS inhibitor L-NMMA (10−5 mol l−1), conﬁrming that the inotropic
effects of L-arginine were indeed NOS dependent (Fig. 2B).
Administration of SIN-1 in the presence of superoxide dismutase,
induced a negative inotropism in eel and frog and, in contrast again, a
positive inotropism in iceﬁsh (Fig. 2C).
3.4. NOS-NO involvement in the nitrite-dependent inotropy
Since NO and nitrite similarly affect the heart, to clarify whether
the inotropic effect of nitrite involves NOS-produced NO, we
exposed the isolated hearts of all species to nitrite (10−5 mol l−1)
alone (Fig. 3A) and in the presence of the NOS inhibitors L-NMMA
(10−5 mol l−1;Fig. 3B) or L-NIO (10−5 mol l−1; Fig. 3C). These
treatments abolished nitrite-dependent negative inotropism in eel
and positive inotropism in iceﬁsh. In contrast, in the frog heart NOS
inhibition did not modify the nitrite-induced negative inotropism
(Figs. 3B, C). To test whether nitrite reduction to NO is involved in
the nitrite-dependent inotropy, we exposed the isolated hearts of allFig. 2. Effect of L-arginine on stroke volume (Vs) and stroke work (Ws) in isolated and
perfused hearts of eel (10−7 mol l−1), iceﬁsh (10−6 mol l−1) and frog (10−7 mol l−1)
before (A) and after (B) treatment with L-NMMA (10−5 mol l−1) (n=4–7). (C) Effect
of SIN-1 (in presence of SOD 10 IU/ml) on stroke volume (Vs) and stroke work (Ws) in
eel (10−7 mol l−1), iceﬁsh (10−5 mol l−1) and frog (10−7 mol l−1) (n=4–5).
Percentage changes were evaluated as means±S.E.M. Asterisks indicate values
signiﬁcantly different from the control value: ⁎Pb0.05.species to nitrite (10−5 mol l−1) alone (Fig. 3A) and in the presence
of a NO scavenger PTIO (10−7mol l−1;Fig. 3D). PTIO did notmodify the
nitrite-induced inotropism in both eel and iceﬁsh, while it abolished
the negative inotropic effects exerted by nitrite in frog (Fig. 3D).
3.5. cGMP-PKG involvement in the nitrite-dependent inotropism
In the mammalian heart, activation of the NO-sGC pathway can
mediate negative inotropy. To verify the involvement of cGMP-PKG
cascade, cardiac preparations of eel and frog were perfused, in
presence of nitrite, either with ODQ (10−5 mol l−1), an oxidant and a
soluble guanylate cyclase inhibitor, or with a protein kinase G blocker
KT5823 (10−7 mol l−1). (Obvious logistic difﬁculties in Antarctica
prevented in iceﬁsh parallel experiments described in this and in the
following section). As shown in Fig. 4B, in both species ODQ and
KT5823 treatments abolished the negative inotropic effect of nitrite,
supporting the involvement of the NO-sGC-PKG pathway in the nitrite
actions (Fig. 4C).
3.6. Analysis of S-nitrosylated proteins
In the eel cardiac tissues, the analysis of S-nitrosylated proteins
revealed no differences in the cytosolic fractions, while in the
membrane fractions a major expression of both low and high
molecular weight S-nitrosylated proteins were present (Fig. 5).
In the frog cardiac tissues, the analysis of S-nitrosylated proteins
revealed differences in both the cytosolic and membrane fractions, in
particularly at low molecular weight (Fig. 6).
4. Discussion
Using in vitro isolated and perfused working heart preparations of
teleost ﬁsh, i.e. the eel A. anguilla and the hemoglobinless iceﬁsh C.
Fig. 4. Effect of nitrite (10−5 mol l−1) on stroke volume (Vs) and stroke work (Ws) in
isolated and perfused hearts of eel and frog before (A) and after treatment with ODQ
(10−5 mol l−1) (B) or KT5823 (10−7 mol l−1) (C) (n=3–5). Percentage changes were
evaluated as means±S.E.M. Asterisks indicate values signiﬁcantly different from the
control value: ⁎Pb0.05.
Fig. 5. Western blot analysis of S-nitrosylated proteins in eel heart homogenates.
Cytosolic (A) and membrane protein fractions (B). CTRL: control; NITRITE: nitrite
treated-hearts.
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histories and ecophysiological traits, we provided heart paradigms
well suited for highlighting the signalling properties of nitrite in a
comparative vertebrate context. In particular, the distinct morpho-
functional traits (see Table 2 for references) of these heart designs
(fully trabeculated myoarchitecture supplied by avascular intertrabe-
cular system of lacunae) allow assessment of nitrite-elicited contrac-
tile myocardial effects free from concomitant vascular (coronary)
responses. Like in the highly vascularized mammalian heart [i.e. rat,
21], we found that nitrite exerts a remarkable contractile inﬂuence on
the heart of the three species, regardless of their difference in vascular
organization, i.e. avascular (frog, iceﬁsh) or poorly (eel) vascularized
types of ventricles. We showed that nitrite negatively affects cardiac
mechanical performance by decreasing stroke volume in eel and frog,
while increasing it in the iceﬁsh. Of note, these nitrite-induced
opposite myocardial effects parallel those induced by the direct
cardiac exposure to NO [eel, 16; iceﬁsh, 17; frog, 18], providing a
striking example of the role of nitrite reduction to NO in the heart. It is
conceivable that the positive inotropic response observed in the
iceﬁsh involves the hemoglobinless condition. The already documen-
ted [17] species-speciﬁc differences in the cardiac response to NO
between the iceﬁsh and the eel, cannot be attributed to the
experimental hierarchic level of investigation or to macroscopic
differences in cardiac structure. The possibility exists that the veryexpanded mitochondrial compartment of the iceﬁsh myocytes [17],
plays a role. In zebraﬁsh, exposure to water nitrite (0.6–2 mmol l−1)
was shown to induce an increase of Hb-NO levels which indicates an
augmented NO production [13]. This perturbation in NO homeostasis
was suggested to be responsible for important cardiovascular effects,
including vasodilation and decreased blood pressure, quickly counter-
acted by increased cardiac pumping [22].
Interestingly, although the iceﬁsh lacks Hb, its cardiac tissue
contains myoglobin which may contribute to NO generation by
functioning as nitrite reductase [23]. It is possible that the nitrite-
induced positive inotropism observed in the iceﬁsh is due either to a
distinct spatio-temporal sub-compartmentalization of NOS isoforms,
or to intracellular effectors related to extreme stenothermia, or to the
absence of Hb [17,24].
Interestingly, in contrast to the cardiac responses in eel and frog,
the iceﬁsh heart shows a higher sensitivity to nitrite, the ﬁrst
signiﬁcant increase in stroke volume being obtained at 0.1 μmol l−1.
In aquatic organisms, nitrite sensitivity shows large species variations
[25]. As shown in many types of myocardial preparations, the shift
from nanomolar to micromolar concentrations of intramyocardial NO
and cGMP has been correlated to either positive or negative inotropic
responses, respectively [see 26 for references]. The reason for the
increased nitrite sensitivity of the iceﬁsh heart is unclear although
several factors, to be mechanistically investigated in the future, may
play a role, including the extreme cold adaptation and the stable
oxygen-rich Antarctic waters, as well as the reactive oxygen species
generating/scavenging abilities associated to the Hb-less condition.
Noteworthy, in the frog heart, the nitrite-dependent negative
inotropism is inhibited by NO scavengers but not by NOS inhibitors, a
result consistent with the reduction of nitrite to NO though a NOS-
independentmechanism, as reported in the rat [21]. Contrarily, in both
eel and iceﬁsh, NOS inhibition abolishes the nitrite-induced inotropic
effects, which, however, are not affected by the NO scavenger PTIO,
thus suggesting that nitrite action is not via its reduction toNO. Indeed,
a mammalian-oriented study has suggested that nitrite may also
mediate effects independent of NO generation [12]. The mechanistic
explanation of the different pattern between ﬁsh and frog remains to
be clariﬁed. Since in ﬁsh a functional NOS appears essential for the
inotropic effects exerted by nitrite, the possibility exists that in these
piscine species the NOS isoforms, particularly eNOS, may act as nitrite-
reductase, as suggested in some mammals [7].
Table 2
Different levels of cardiac organization in the vertebrates species examined.
Species Iceﬁsh, frog Eel
Ventricular myoarchitecture Trabecular Trabecular+compact subepicardium
Type of blood supply Venous,
lacunary
Coronary to compact subepicardium,
lacunary to innermost myocardium
Interface EE EE and VE
EE = endocardial-endothelium; VE = vascular endothelium; Ref. in [49].
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frog have a functioning NO axis which modulates mechanical
performance via a NO-dependent increase in cGMP [16–18]. Also in
themammalian heart, several studies have demonstrated a NO-cGMP-
dependent modulation of inotropism [26–29]. In all cases, the NOS
system has been regarded as the exclusive physiological source of NO.
However, here we show that in the heart of eel, iceﬁsh and frog,
physiological levels of nitrite may also be integral sources of NO, thus
strongly supporting the generalized picture emerged in mammalian-
oriented studies. Noteworthy, as described in mammals, nitrite
conversion to NO may occur along oxygen and pH gradients [see 30
for references], a condition which can be of importance in ﬁsh and
amphibians, often exposed to chronic environmental hypoxia [31,32].
In eel and frog, the inhibition of the nitrite-dependent decrease in
stroke volume in presence of ODQ suggests the involvement of the
soluble guanylate cyclase-cGMP axis. Due to the oxidant properties of
ODQ [33], we cannot exclude that this inhibitor interferes with the
reductase ability of tissue hemeproteins, thus limiting the conversion of
nitrite to NO. An important intramyocardial target of cGMP is PKG
[34,35]. The ﬁnding that KT5823, an inhibitor structurally unrelated to
cGMP, abolished the nitrite-induced inotropism in eel and frog is
consistent with a cGMP-PKG-dependent mechanism. Interestingly,
also in the rat heart nitrite effects were abolished by PGK inhibitor
[36, this issue]. In both eel and frog hearts [34], PKG, as shown in the
mammalian myocardium, may reduce L-type Ca2+ currents [37] and
through troponin I phosphorylation reduces troponin C afﬁnity for Ca2+,
thus negatively affecting contractility [38]. We suggest that a reduction
of L-typeCa2+current andaPKG-mediatedmyoﬁlamentdesensitization
to Ca2+may contribute to the nitrite-induced negative inotropism in eel
and frog.
Using the biotin switch method for the speciﬁc tagging of S-
nitrosylated proteins [19], we evaluated the level of nitrosylated
proteins in the hearts of eel and frog treated with nitrite. Protein S-
nitrosylation, the covalent adduction of a nitroso group to a cysteine
thiol side chain, has recently emerged as a major mechanism bywhich
NO mediates a large number of intracellular processes [39]. Our
results showed that nitrite-derived NO induces an increase of protein
S-nitrosylation in both membrane and cytosolic fractions of frog and
in membrane fraction of eel. A study in our laboratory is in progress to
identify the ﬁnal molecular targets of this nitrosylation process and
their subcellular localization.
Recent ﬁndings have shown that S-nitrosylation regulates diverse
pathways, including G-protein-coupled receptor signalling [40,41],Fig. 6. Western blot analysis of S-nitrosylated proteins in frog heart homogenates.
Cytosolic (A) and membrane protein fractions (B). CTRL: control; NITRITE: nitrite
treated-hearts.Hsp90, a chaperone involved in eNOS activation [42] death receptor-
mediated signalling [43], and mitochondrial pro- and anti- apoptotic
cascades [44]. Moreover, dysregulated S-nitrosylation of the ryano-
dine receptor (Ca2+-release channel) may contribute to cardiac
arrhythmias [45], heat stroke [46], and impaired exercise capacity
[47]. In this view, mitochondria deserve particular attention, also in
light of the inhibition exerted by nitrite-derived NO on mitochondrial
respiration observed by Shiva et al. [23] in both heart homogenate and
isolated cardiomyocytes. The present study does not elucidate
whether the negative inotropism observed in eel and frog relates to
an inhibited mitochondrial respiration. Additional studies are needed
in order to clarify whether in the heart of eel, iceﬁsh and frog,
mitochondria are the ﬁnal target of nitrite-derived NO. In this context,
it should be underlined that, as shown by Shiva et al. [23], in the rat
heart nitrite-derived NO reduces mitochondrial respiration through
cytochrome c oxidase.
4.1. Conclusions and perspectives
We have shown in non-mammalian hearts with diverse morphol-
ogies and blood supply that, under normoxic conditions, nitrite
modulates contractility and is also an important intracardiac source of
NO. The different nitrite-dependent inotropic responses, which
parallel those elicited by authentic NO, uncover at the heart level
the already observed species-speciﬁc sensitivity to NO2−, well
documented both in freshwater and marine teleosts [25], as well as
in several amphibian species [48] after exposure to ambient nitrite.
We argue that the comparative approach using different cardiac
designs, such as those employed in this work, provides not only
remarkable insights on “ancestral” functions of the nitrite-NO system
in vertebrates, but also may help to expand its actual signiﬁcance in
human physiology. Indeed, these natural heart models represent
powerful research systems that complement the more traditional
models of human diseases, like themouse, holding important clues for
understanding fundamental cardiovascularmechanisms. For example,
the phylogenetic relationship among Hb-expressing and Hb-less ﬁsh
families constitutes an ideal matrix of genetic knockouts that can be
employed to probe several challenging questions pertinent to the
redox biome, including the newly discovered role of Hb and Mb as the
predominant nitrite reductases able to generate and regulate NO
signalling. By using the heart of the iceﬁsh C. hamatus, natural knock-
out for Hb, and an Hb-free perfusion buffer, we demonstrated that Hb
is not involved in the reduction of nitrite to NO in the myocardial
tissue, thus corroborating the theory [23] that in the heart myoglobin
may be the predominant nitrite reductase. In conclusion, comparative
studies may pave the way towards an integrated systemic approach
concerned with the role of nitrite/NO signalling in vertebrate cardiac
physiology, which is also essential for medically-oriented studies and
clinical applications.
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